These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21305439)

  • 21. [Contrast echocardiography and ST-segment elevation].
    Alonso Gómez AM; Rekondo Olaetxea J; Robledo Iñarritu M; Arós Borau F
    Rev Esp Cardiol; 2011 Nov; 64(11):1071-3. PubMed ID: 21664753
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety With Echocardiographic Contrast Agents.
    Muskula PR; Main ML
    Circ Cardiovasc Imaging; 2017 Apr; 10(4):. PubMed ID: 28377467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasound microbubble contrast and current clinical applications.
    Dindyal S; Kyriakides C
    Recent Pat Cardiovasc Drug Discov; 2011 Jan; 6(1):27-41. PubMed ID: 21222650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast enhanced ultrasound in pediatric patients: a real challenge.
    Schreiber-Dietrich DG; Cui XW; Piscaglia F; Gilja OH; Dietrich CF
    Z Gastroenterol; 2014 Oct; 52(10):1178-84. PubMed ID: 25313631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications.
    Piscaglia F; Nolsøe C; Dietrich CF; Cosgrove DO; Gilja OH; Bachmann Nielsen M; Albrecht T; Barozzi L; Bertolotto M; Catalano O; Claudon M; Clevert DA; Correas JM; D'Onofrio M; Drudi FM; Eyding J; Giovannini M; Hocke M; Ignee A; Jung EM; Klauser AS; Lassau N; Leen E; Mathis G; Saftoiu A; Seidel G; Sidhu PS; ter Haar G; Timmerman D; Weskott HP
    Ultraschall Med; 2012 Feb; 33(1):33-59. PubMed ID: 21874631
    [No Abstract]   [Full Text] [Related]  

  • 26. Bubble trouble: anaphylactic shock, threatened myocardial infarction, and transient renal failure after intravenous echo contrast for left ventricular cavity opacification preceding dobutamine stress echo.
    Ionescu A
    Eur J Echocardiogr; 2009 Jul; 10(5):707-10. PubMed ID: 19525512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part V - EUS-Guided Therapeutic Interventions (short version).
    Fusaroli P; Jenssen C; Hocke M; Burmester E; Buscarini E; Havre RF; Ignee A; Saftoiu A; Vilmann P; Nolsøe CP; Nürnberg D; D'Onofrio M; Gilja OH; Lorentzen T; Piscaglia F; Sidhu PS; Dietrich CF
    Ultraschall Med; 2016 Aug; 37(4):412-20. PubMed ID: 27490463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound contrast agent safety: from anecdote to evidence.
    Main ML
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1057-9. PubMed ID: 19761982
    [No Abstract]   [Full Text] [Related]  

  • 29. Contrast-enhanced ultrasound using sulfur hexafluoride is safe in the pediatric setting.
    Torres A; Koskinen SK; Gjertsen H; Fischler B
    Acta Radiol; 2017 Nov; 58(11):1395-1399. PubMed ID: 28173725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Case Report of Cardiac Arrest After Intravenous Administration of Sulfur Hexafluoride (Lumason
    Arnouk S; Huynh Q; Saric M; Papadopoulos J
    J Pharm Pract; 2024 Apr; 37(2):509-512. PubMed ID: 36803045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Off-Label Use of Ultrasound Contrast Agents for Intravenous Applications in Children: Analysis of the Existing Literature.
    Rosado E; Riccabona M
    J Ultrasound Med; 2016 Mar; 35(3):487-96. PubMed ID: 26839372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of adverse events associated with use of perflutren contrast agents for echocardiography.
    Herzog CA
    JAMA; 2008 May; 299(17):2023-5. PubMed ID: 18460662
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety and Tolerability of SonoVue® in Patients with Large Artery Anterior Circulation Acute Stroke.
    Baracchini C; Viaro F; Favaretto S; Palmieri A; Kulyk C; Causin F; Farina F; Ballotta E
    J Neuroimaging; 2017 Jul; 27(4):409-413. PubMed ID: 28000971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the hemolytic potential of Optison and Albunex in whole human blood in vitro: acoustic pressure, ultrasound frequency, donor and passive cavitation detection considerations.
    Miller MW; Everbach EC; Cox C; Knapp RR; Brayman AA; Sherman TA
    Ultrasound Med Biol; 2001 May; 27(5):709-21. PubMed ID: 11397535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ultrasonographic contrast media].
    Drudi F
    Radiol Med; 2004 Apr; 107(4 Suppl 1):36-7. PubMed ID: 15323321
    [No Abstract]   [Full Text] [Related]  

  • 36. Contrast-enhanced ultrasound for evaluation of high-intensity focused ultrasound treatment of benign uterine diseases: retrospective analysis of contrast safety.
    Cheng CQ; Zhang RT; Xiong Y; Chen L; Wang J; Huang GH; Li KQ; Zhang L; Bai J
    Medicine (Baltimore); 2015 Apr; 94(16):e729. PubMed ID: 25906100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primum non nocere.
    Roddick A
    N Z Dent J; 2006 Mar; 102(1):3. PubMed ID: 16568880
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety Analysis of Adverse Events of Ultrasound Contrast Agent Lumason/SonoVue in 49,100 Patients.
    Li Q; Yang K; Ji Y; Liu H; Fei X; Zhang Y; Li J; Luo Y
    Ultrasound Med Biol; 2023 Feb; 49(2):454-459. PubMed ID: 36357252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety profile of ultrasound enhancing agents in echocardiography.
    Kumar S; Purtell C; Peterson A; Gibbons P; Khan AM; Heitner SB
    Echocardiography; 2019 Jun; 36(6):1041-1044. PubMed ID: 31038768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Has Hippocrates had his day?
    de Grey AD
    Rejuvenation Res; 2006; 9(3):371-3. PubMed ID: 16859477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.